Is NanoVibronix Inc (NAOV) a Stock to Watch After Gaining 30.49% This Week?

NanoVibronix Inc (NAOV) stock has gained 30.49% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

NanoVibronix Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on NAOV!

See Full NAOV Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With NAOV Stock Today?

NanoVibronix Inc (NAOV) stock is trading at $1.07 as of 2:28 PM on Thursday, Jan 25, a gain of $0.16, or 17.6% from the previous closing price of $0.91. Volume today is elevated. So far 1,783,888 shares have traded compared to average volume of 32,207 shares. The stock has traded between $0.89 and $1.15 so far today. To see InvestorsObserver's Sentiment Score for NanoVibronix Inc click here.

More About NanoVibronix Inc

NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low frequency, low intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients as well as through distributor agreements. Click Here to get the full Stock Report for NanoVibronix Inc stock.